Ayurveda and Bioactives as Adjuvant for DNA Modulation in Cancer Treatment and Adverse Drug Reaction – A Glimpse of Traditional Indian Nanotechnology

The document explores the integration of Ayurvedic herbs and bioactives, such as Curcumin, Quercetin, and Tulsi, with conventional cancer treatments to mitigate adverse drug reactions (ADRs) and enhance efficacy. It highlights that 50% of cancer patients experience moderate ADRs, while 20-30% face severe ones like hair loss and immunity loss. Observations from several cases treated with Ayurveda show promising results, including extended survival and reduced ADRs. The study also discusses the role of traditional Indian nanotechnology and bioactives in DNA modulation, emphasizing the need for further clinical research to validate these findings and suggesting that Ayurvedic treatments could offer a cost-effective and safer alternative to conventional therapies.